Hiv aids

The Alabama Vaccine Research Clinic (AVRC) at UAB is seeking adults in Alabama to join a confidential research study evaluating a new PREP option. You may qualify if you: Are 18 or older and HIV negative Have had condomless receptive anal sex in the past year Meet at least one other risk factor (multiple partners, a recent STI, or stimulant use with sex) Participants receive study-related care at no cost and compensation for their time. Learn more or see if you qualify by calling 205-934-7492 or visiting sites.uab.edu/avrc/contact-us.

Researchers at UAB are studying a new HIV vaccine designed to stimulate strong, targeted immune responses. We are looking for HIV-negative adults ages 18–55 who are in overall good health to participate in this Phase 1 study. Visits include safety checks, blood draws, and scheduled vaccinations. Compensation is provided for eligible participation. Call 205-934-7492 or email avrc@uabmc.edu

For more than 30 years, UAB’s Alabama Clinical Research Site has been at the forefront of HIV and infectious disease research, conducting studies through national clinical trials networks. We are currently building a registry of adults who are interested in being contacted about future research opportunities at the Alabama Clinical Research Site. People we are looking for include: Adults 18 and older who live in or near Birmingham People who are living with HIV and receiving care People who do not have HIV but are interested in HIV prevention, vaccines, or other infectious disease research Community members from groups most impacted by HIV in Alabama who want to help shape future prevention and treatment options Joining the registry only means we may contact you to explain future studies; you are never obligated to enroll. If you are eligible and choose to participate in a study, you may receive compensation for your time and travel. For more information or to be added to our registry, call 205-934-7492 or email us at avrc@uabmc.edu

The Alabama Vaccine Research Clinic (AVRC) at UAB is seeking healthy adults ages 18 to 65 to take part in a national HIV prevention study. This Phase 2 clinical trial is testing the safety and potential benefits of three investigational monoclonal antibodies—lab-made proteins that may help the body block HIV. These antibodies are given by IV infusion, not as a shot or vaccine, and participants are never exposed to HIV. Those who qualify will receive two infusions over six months, followed by routine clinic visits for up to one year. Participants will receive compensation for their time and effort. To learn more, call 205-934-7492, email avrc@uabmc.edu.

Do you struggle with anxiety, depression, or feel that your quality of life has suffered due to your HIV diagnosis? Researchers in the Department of Psychology at The University of Alabama at Birmingham are conducting a clinical trial of Acceptance and Commitment Therapy for the treatment of mental health concerns among men who have sex with men and are living with HIV. Volunteers will attend 8 weekly roughly 1 hour sessions of psychotherapy delivered via HIPAA-compliant Zoom by a doctoral student in Medical/Clinical Psychology at University of Alabama at Birmingham. Participants will receive $10 upon completion of initial intake session and an additional $15 upon completion of final therapy session. To participate, you must be an active patient of UAB's 1917 clinic. Complete this online screener to indicate interest. Reach out to uabACThivtrial@gmail.com with any questions.

426c.Mod.Core-C4b adjuvanted with 3M-052-AF + Alum immunization in combination with an antiretroviral analytical treatment interruption (ATI) in people living with HIV for elicitation of VRC01-lineage antibodies Study Information: Are you 18-60 years of age living with HIV, and want to be a part of a vaccine study? Is your viral load suppressed/undetectable? Are you able to receive a vaccine? Are you generally healthy? Are you willing to temporarily stop taking antiretrovirals? You may qualify for a study looking at testing an experimental HIV vaccine with an experimental adjuvant to see how the immune responses change among participants who do an antiretroviral analytical treatment interruption (ATI) compared to those who do not. Compensation at each study visit will be provided for time and travel. Transportation services are also available upon request. If interested, please email sspaulding@uabmc.edu.

Are you: A woman who has ever been in jail, prison, or on probation or parole? A woman who has used drugs? Interested in learning about a way to protect yourself against HIV?   You may qualify for a paid research study at the University of Alabama at Birmingham, in partnership with Yale University. Participate in confidential study interviews at our research office. Earn $50 for each interview, up to $225 for participating in the study. Fill out our contact survey here. Or you may call 205-934-2851 or email AthenaStudy@uabmc.edu.

This study will examine predictors of successful aging outcomes among adults and older adults with and without HIV. We are currently recruiting HIV-negative controls, thus to qualify, you must be HIV-negative, age 50 or older, be proficient in English, must not be mentally impaired or have significant neuromedical issues, and must consent to a blood draw. Eligible participants may be compensated up to $150 for a ~5-hour visit. For more information, please call 205-934-2862.